11th Annual World ADC Awards

11 Years of Recognizing & Celebrating Top Caliber Achievements, Differentiation & Impact in Antibody-Drug Conjugate Development

The ADC field continues to go from strength to strength with transformative clinical advancements for oncology patients, new companies entering the field, and game changing ADC technologies. As the community reunites at World ADC San Diego, it is important to reflect and recognize the long-term contributors, novel and innovative programs, and upcoming pioneers who have gone above and beyond to ensure the continued success of the field.

Taking place after scientific program day two, the 11th Annual World ADC Awards serves as your opportunity to celebrate amazing individual work, extraordinary endeavors, teamwork, and commercial acumen over the past 12 months to progress ADCs towards standard of care treatments.

Make sure you have your say and cast your nominations across the 10 award categories, with shortlisted nominees submitting proposals to our expert judging panel to select the 2024 winners and runners.

2024 Awards Timeline

  • Thursday, July 18: Nominations open – cast your vote for each category!
  • Friday, August 16: Nominations close
  • Monday, August 26: Shortlisted nominees with the most votes are published
    • Shortlisted nominees are contacted to submit their proposal to the World ADC judges
  • Friday, September 27: Submission deadline for proposals from shortlisted nominees
  • Early October: Judging panel meet to decide the 2024 winners and runners up
    • Proposals are individually scored by judges according to published award category criteria
    • The winner and runners up are selected with the highest cumulative score
  • Wednesday, November 6: Winners are announced at World ADC Awards ceremony

2024 Judges

Greg Thurber

Associate Professor & Chair, Graduate Education

University of Michigan

Ian Schwartz

Senior Director, Bioconjugation Process


Jagath Reddy Junutula

President & Chief Executive Officer

Aarvik Therapeutics

John Lambert

Independent Consultant & Honorary Professor

Queens University Belfast

Gail Lewis

Senior Principal Scientist


Puja Sapra

Senior Vice President, Biologics Engineering & Oncology Targeted Discovery, Oncology R&D


Rakesh Dixit

President & Chief Executive Officer

Bionavigen Oncology

Robert Lutz

Chief Science Officer

Iksuda Therapeutics

2023 Memorable Highlights

ADC Awards-12
ADC Awards-82 (1) (1)
ADC Awards-56 (1) (1)


Each year, during the World ADC Awards’s team alongside a panel of independent judges select scientists, researchers, and drug developers who are progressing ADCs to the front-line as life changing treatments for those patients diagnosed with cancer.

For more information about World ADC San Diego and the World ADC Awards please visit: www.worldadc-usa.com and www.worldadc-awards.com

Partnership Opportunities

Partner with the World ADC Awards in recognizing leaders and visionaries who are being recognized by industry experts for their innovations, services, and dedication to the ADC field.

From promotion and brand awareness to networking opportunities and increased reputation, being an ADC Award sponsor has many benefits that you may not have even thought of.

About World ADC Series

The World ADC team ploughs its collective energy in to sourcing the insights you need. We investigate the most challenging problems facing the industry; source the leading experts who have game-changing solutions; and distil this into accessible formats of information exchange – for you. From globally leading conferences to webinars and industry reports, whatever the information you need, World ADC can offer you the insights you need to accelerate your ADC programs.

The value World ADC provides you is the power of insight and connections. Not artificial, and not short-lived. We nurture the right environments in which people can communicate problems and solutions; share novel data and forge networks across the industry that will make each of your endeavours more informed and more robust.

We share a common belief with the industry – that the potential of antibody drug conjugates is enormous. In the war against cancer, ADCs can be a game-changer and we know that the right insights and connections can sharpen the weapons that are in your arsenal.

Join us at the heart of the ADC community to improve your programmes and be part of the mission to develop better antibody drug conjugate drugs.